Protein kinase Ctheta negatively regulates store-independent Ca2+ entry and phosphatidylserine exposure downstream of glycoprotein VI in platelets.
Platelet activation must be tightly controlled to provide an effective, but not excessive, response to vascular injury. Cytosolic calcium is a critical regulator of platelet function, including granule secretion, integrin activation, and phosphatidylserine (PS) exposure. Here we report that the novel protein kinase C isoform, PKCtheta, plays an important role in negatively regulating Ca(2+) signaling downstream of the major collagen receptor, glycoprotein VI (GPVI). This limits PS exposure and so may prevent excessive platelet procoagulant activity. Stimulation of GPVI resulted in significantly higher and more sustained Ca(2+) signals in PKCtheta(-/-) platelets. PKCtheta acts at multiple distinct sites. PKCtheta limits secretion, reducing autocrine ADP signaling that enhances Ca(2+) release from intracellular Ca(2+) stores. PKCtheta thereby indirectly regulates activation of store-operated Ca(2+) entry. However, PKCtheta also directly and negatively regulates store-independent Ca(2+) entry. This pathway, activated by the diacylglycerol analogue, 1-oleoyl-2-acetyl-sn-glycerol, was enhanced in PKCtheta(-/-) platelets, independently of ADP secretion. Moreover, LOE-908, which blocks 1-oleoyl-2-acetyl-sn-glycerol-induced Ca(2+) entry but not store-operated Ca(2+) entry, blocked the enhanced GPVI-dependent Ca(2+) signaling and PS exposure seen in PKCtheta(-/-) platelets. We propose that PKCtheta normally acts to restrict store-independent Ca(2+) entry during GPVI signaling, which results in reduced PS exposure, limiting platelet procoagulant activity during thrombus formation.
Harper
Matthew T
MT
Department of Physiology and Pharmacology, School of Medical Sciences, University of Bristol, BS8 1TD Bristol, United Kingdom.
Poole
Alastair W
AW
D000081:Acetamides / Q000494:pharmacology; D000244:Adenosine Diphosphate / Q000378:metabolism; D000818:Animals; D001792:Blood Platelets / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D002118:Calcium / Q000378:metabolism*; D004075:Diglycerides / Q000494:pharmacology; D005434:Flow Cytometry; D017136:Ion Transport / Q000187:drug effects; D007527:Isoenzymes / Q000235:genetics / Q000378:metabolism*; D007546:Isoquinolines / Q000494:pharmacology; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D010718:Phosphatidylserines / Q000378:metabolism*; D015539:Platelet Activation / Q000187:drug effects; D010980:Platelet Membrane Glycoproteins / Q000378:metabolism*; D011493:Protein Kinase C / Q000235:genetics / Q000378:metabolism*; D000074121:Protein Kinase C-theta; D015398:Signal Transduction / Q000187:drug effects
D000081:Acetamides; D004075:Diglycerides; D007527:Isoenzymes; D007546:Isoquinolines; D010718:Phosphatidylserines; D010980:Platelet Membrane Glycoproteins; C098341:platelet membrane glycoprotein VI; C081356:LOE 908; D000244:Adenosine Diphosphate; C038237:1-oleoyl-2-acetylglycerol; C489593:Prkcq protein, mouse; D011493:Protein Kinase C; D000074121:Protein Kinase C-theta; D002118:Calcium
Eur J Biochem. 1997 Oct 15;249(2):547-55
9370366
Blood. 2009 Jul 9;114(2):489-91; author reply 491-2
19589937
Microcirculation. 2008 May;15(4):269-82
18464157
Arterioscler Thromb Vasc Biol. 2005 Dec;25(12):2673-8
16254207
J Physiol. 2006 Oct 1;576(Pt 1):151-62
16857711
J Thromb Haemost. 2008 Aug;6(8):1253-61
18513212
J Biol Chem. 2003 Aug 1;278(31):29031-40
12721302
Blood. 2009 Mar 12;113(11):2557-67
19164598
Arterioscler Thromb Vasc Biol. 2008 Apr;28(4):746-51
18258814
Mol Pharmacol. 1993 May;43(5):655-9
7684814
Arterioscler Thromb Vasc Biol. 2008 Mar;28(3):403-12
18174460
Arterioscler Thromb Vasc Biol. 2006 Jan;26(1):41-8
16254201
Biochemistry. 1995 Aug 22;34(33):10448-55
7654698
J Biol Chem. 2007 Mar 9;282(10):7046-55
17210570
Physiol Rev. 2005 Apr;85(2):757-810
15788710
J Clin Invest. 2009 Feb;119(2):399-407
19147982
J Neurol Sci. 2000 Sep 15;178(2):107-13
11018702
Cell Calcium. 2009 May;45(5):413-20
19285721
Mol Pharmacol. 2005 Feb;67(2):558-63
15533987
Biophys J. 1995 Nov;69(5):2112-24
8580355
Arterioscler Thromb Vasc Biol. 1999 Dec;19(12):2841-6
10591659
Biochem J. 1989 Mar 15;258(3):923-6
2730577
Naunyn Schmiedebergs Arch Pharmacol. 1994 Mar;349(3):301-7
7516040
J Biol Chem. 1985 Mar 25;260(6):3440-50
3838314
Basic Clin Pharmacol Toxicol. 2005 Apr;96(4):316-24
15755315
J Thromb Haemost. 2003 Jul;1(7):1602-12
12871297
Blood. 2009 Feb 26;113(9):2056-63
18832659
Thromb Haemost. 2005 Oct;94(4):839-45
16270640
Nature. 2007 Mar 15;446(7133):284-7
17361175
Arterioscler Thromb Vasc Biol. 2009 Nov;29(11):1883-9
19696403
Thromb Haemost. 1993 Dec 20;70(6):1024-9
8165595
J Thromb Haemost. 2006 Mar;4(3):648-55
16460447
J Biol Chem. 2004 Feb 20;279(8):7241-6
14662757
J Thromb Haemost. 2009 Jul;7(7):1057-66
19422456
Blood. 2002 Oct 15;100(8):2801-11
12351388
Biochim Biophys Acta. 2004 Mar 22;1636(2-3):119-28
15164759
Biochem Soc Trans. 2007 Nov;35(Pt 5):1005-8
17956264
Blood. 2009 Jan 15;113(3):675-8
18952890
Cell Signal. 2009 Apr;21(4):457-61
19049864
PLoS One. 2008 Sep 25;3(9):e3277
18815612